Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain

Published:2006-11 Issue:S1 Volume:24 Page:49-59
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Shearer Arran T.,Bagust Adrian,Ampudia-Blasco F. Javier,Martínez-Lage Álvarez Belén,Pérez Escolano Isabel,París Gonzalo

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.2165/00019053-200624001-00005.pdf

Reference56 articles.

1. International Diabetes Federation. Diabetes Atlas 2001. Brussels: International Diabetes Federation; 2001

2. Vázquez JA, Gaztambide S, Soto-Pedre E. Estudio prospectivo a 10 años sobre la incidencia y factores de riesgo de diabetes mellitus tipo 2. [in Spanish]. Med Clin (Barc) 2000; 115: 534–9

3. Mata M, Antoñanzas F, Tafalla M, Sanz P. El coste de la diabetes tipo 2 en España, El estudio CODE-2. [in Spanish]. Gac Sanit 2002; 16: 511–20

4. Oliva J, Lobo F, Molina B, Monereo S. Direct health care costs of diabetic patients in Spain. Diabetes Care 2004; 27: 2616–21

5. Goday A, Franch Nadal J, Mata M, et al. Criterios y pautas de terapia combinada en la diabetes tipo 2. Documento de consenso de la Sociedad Española de Diabetes y de la Sociedad Española de Medicina Familiar y Comunitaria [in Spanish]. Endocrinología y Nutrición 2001; 48: 82–97

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database;Diabetes, Obesity and Metabolism;2013-04-18

2. Progression to Insulin for Patients with Diabetes Mellitus Using the Texas Medicaid Database;Clinical Therapeutics;2011-12

3. Public health and prevention in Europe: is it cost-effective?;Journal of Pharmaceutical Health Services Research;2011-06-24

4. The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications;The European Journal of Health Economics;2011-06-10

5. Relationships among Self-Management, Patient Perceptions of Care, and Health Economic Outcomes for Decision-Making and Clinical Practice in Type 2 Diabetes;Value in Health;2010-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3